TPG Growth Acquires Implantable Provider Group (IPG)

Evolent Health Acquires IPG from TPG Growth for $375M

June 29, 2022

Healthcare Services

Evolent Health agreed to acquire IPG, a provider of surgical cost management solutions for musculoskeletal conditions, from TPG Growth for $375 million in cash plus up to $87 million of contingent consideration. The IPG platform will be integrated into Evolent’s New Century Health business to expand the company's value-based specialty care capabilities and add new payer and ambulatory surgery center relationships; the deal is expected to be immediately accretive to adjusted EBITDA.

TPG Growth Invests in Compass Surgical Partners

January 23, 2024

Healthcare Services

TPG Growth has made a strategic growth equity investment in Compass Surgical Partners, participating alongside existing investor Health Velocity Capital. The capital will be used to accelerate Compass's expansion of ambulatory surgery center (ASC) joint ventures with health systems and physician groups across the U.S.; terms were not disclosed.

TPG Growth Takes Minority Stake in Ideal Image

May 11, 2021

Healthcare Services

TPG Growth acquired a significant minority stake in Ideal Image, North America’s leading medical aesthetics brand, while L Catterton remains the majority owner. The investment will support Ideal Image’s tele-consultation platform and expansion of its national point-of-care network; financial terms were not disclosed.

TPG Makes >$100M Growth Investment in EIS

June 29, 2021

Cloud & SaaS

TPG, via its TPG Tech Adjacencies fund, made a growth investment of more than $100 million in EIS, a San Francisco–based cloud-native insurance software platform. The capital will be used to accelerate product development across risk, health and wealth lines and to support geographic expansion.

TPG Growth Makes Strategic Growth Investment in K2 Medical Research

June 17, 2024

Healthcare Services

TPG (TPG Growth) has made a strategic growth investment in K2 Medical Research to partner with management and scale K2’s integrated clinical trial site platform. K2, headquartered in the Orlando/Maitland, Florida area, operates several de novo sites focused on CNS and other complex therapeutic-area trials and has participated in more than 150 studies for over 35 pharma and biotech sponsors; terms were not disclosed.

TPG Acquires Peppertree Capital Management

July 2, 2025

Infrastructure

TPG Inc. has completed its acquisition of Peppertree Capital Management, adding a $7.8 billion communications infrastructure investing strategy that will operate as TPG Peppertree. The business will be led by Peppertree's Co-Managing Partners Howard Mandel and Ryan Lepene and expands TPG's footprint in digital infrastructure, bringing pro forma AUM to $258 billion.